BRIEF-Peregrine Pharma drops in premarket after discrepancies discovered in bavituximab trial data

NEW YORK, Sept 24 Mon Sep 24, 2012 5:33pm IST

Related Topics

Stocks

   

NEW YORK, Sept 24 (Reuters) - Peregrine Pharmaceuticals Inc : * Pharma drops 71.2 percent to $1.55 in premarket after discrepancies discovered in bavituximab trial data

FILED UNDER: